Treating SLE in ESRD May Boost Survival
Tuesday, October 11, 2011
Researchers find that contrary to frequent practice, continued ongoing treatment improves survival among lupus patients who have developed severe kidney disease.
The finding suggests that SLE in the ESRD population may be underrecognized and undertreated, said lead investigator Anna R. Broder, MD, Assistant Professor of Medicine at Albert Einstein College of Medicine, Bronx, NY.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms